NDC 50228-464
Pregabalin Extended Release 330 mg tablet, film coated, extended release
On the label: ScieGen Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| ScieGen Pharmaceuticals, INC. | Hauppauge, NY, United States | Makes it | Problems found, fixed voluntarilyMay 15, 2026 · 15 inspections, 1 with FDA action |
Product details
- Generic drug
- Pregabalin: every company that makes it
- Form
- tablet, film coated, extended release, oral
- Strength
- 330 mg
- Approval
- ANDA ANDA215675
- On the market since
- Sep 14, 2022
- Package NDCs
50228-464-0550228-464-30- Official label
- DailyMed (National Library of Medicine), updated Sep 19, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?